hi Matt, I’m no expert with FA in all honesty but suggest - checking out their weekly updates every mon as starters to get an understanding of their growth (understandably limited time frame as not an established blue chip). It does look like they’re steadily gaining market share from big 4 - it’s definitelty not a covid immune healthcare stock as recent vic locldown does have a material effect on their earning potential (& factored in to their current flattening in share price hence the opportunity for long term inv at lower entry) - have a look at their board of directors & ppl running it & their performance in prior companies
I’ve been holding for a while & if there are some pragmatic reasons against it please do feel free to share. Neither blind faith in extreme growth nor constant downramping is of aby use (majority will see through it). I don’t believe I know it all (not sure anyone has seen the future tbh) & opem to hearing all valid arguments.
TYR Price at posting:
$3.74 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)